Overview

Comparing Heavy Levobupivacaine With Enantiomeric Excess of 50% and Heavy Racemic Bupivacaine.

Status:
Withdrawn
Trial end date:
1969-12-31
Target enrollment:
0
Participant gender:
All
Summary
The purpose of this study is to compare the non-inferiority between Heavy Levobupivacaine with Enantiomeric Excess of 50% and Heavy Racemic Bupivacaine During Spinal Anesthesia for Orthopedic Procedures in the Lower Limbs.
Phase:
Phase 3
Accepts Healthy Volunteers?
Accepts Healthy Volunteers
Details
Lead Sponsor:
Cristália Produtos Químicos Farmacêuticos Ltda.
Collaborators:
Irmandade da Santa Casa de Misericordia de Sao Paulo
Serviço Social da Indústria do Papel, Papelão e Cortiça do Estado de São Paulo
Treatments:
Bupivacaine
Levobupivacaine
Criteria
Inclusion Criteria:

- ASA (American Society of Anesthesiologists) I or ASA II

- Spinal Anaesthesia for lower limb surgery

- Patient Consent

Exclusion Criteria:

- relative or absolute contraindications for spinal anesthesia

- history of hypersensitivity to the local anesthetics or components

- opioids for anesthetic adjuvant

- spinal lesions, peripheral neuropathies or any other neurologic disorders that leads
to changes of sensitivity

- Body mass index = or > 35

- lumbar puncture difficulty

- ventricular extrasystoles

- dementia, others loss of cognitive ability

- difficulty in the spine

- spinal cord surgery

- anaphylactic reactions or Stevens-johnson Syndrome

- polytraumatism

- alcoholism abuse and use of illicit substance

- Changes in the blood test

- Others conditions judged by investigator's opinion